| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3978378 | Bulletin du Cancer | 2015 | 4 Pages |
Abstract
With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments against the use of cytotoxics in presence of a targetable alteration.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nicolas Girard,